Page 1 | Search Results | Cancer Immunology Research | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Abstract A85: Identification and enrichment for rare naturally occurring tumor-reactive T cells in the tumor microenvironment reveals new and diverse opportunities for cancer immunotherapy

Daniel J. Powell, Jr

Cancer Immunol Res (2015) 3 (10_Supplement): A85.

https://doi.org/10.1158/2326-6074.TUMIMM14-A85

Published: 09 October 2015

View article titled, Abstract A85: Identification and enrichment for rare naturally occurring tumor-reactive T cells in the tumor microenvironment reveals new and diverse opportunities for cancer immunotherapy

Journal Articles

Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer

Katarzyna Urbanska, Caitlin Stashwick, Mathilde Poussin, Daniel J. Powell, Jr

Cancer Immunol Res (2015) 3 (10): 1130–1137.

https://doi.org/10.1158/2326-6066.CIR-15-0047

Published: 04 October 2015

View article titled, Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer

Includes: Supplementary data

Journal Articles

CD4⁺ T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8⁺ T-cell Targeting of HER2/neu–Expressing Cancers

Jashodeep Datta, Shuwen Xu, Cinthia Rosemblit, Jenessa B. Smith, Jessica A. Cintolo, Daniel J. Powell, Jr, Brian J. Czerniecki

Cancer Immunol Res (2015) 3 (5): 455–463.

https://doi.org/10.1158/2326-6066.CIR-14-0208

Published: 03 May 2015

View article titled, CD4+ T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8+ T-cell Targeting of HER2/neu–Expressing Cancers

Includes: Supplementary data

Journal Articles

T Cells Bearing a Chimeric Antigen Receptor against Prostate-Specific Membrane Antigen Mediate Vascular Disruption and Result in Tumor Regression

Stephen P. Santoro, Soorin Kim, Gregory T. Motz, Dimitrios Alatzoglou, Chunsheng Li, Melita Irving, Daniel J. Powell, Jr, George Coukos

Cancer Immunol Res (2015) 3 (1): 68–84.

https://doi.org/10.1158/2326-6066.CIR-14-0192

Published: 06 January 2015

View article titled, T Cells Bearing a Chimeric Antigen Receptor against Prostate-Specific Membrane Antigen Mediate Vascular Disruption and Result in Tumor Regression

Includes: Supplementary data

Journal Articles

Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo

Evripidis Lanitis, Mathilde Poussin, Alex W. Klattenhoff, Degang Song, Raphael Sandaltzopoulos, Carl H. June, Daniel J. Powell, Jr

Cancer Immunol Res (2013) 1 (1): 43–53.

https://doi.org/10.1158/2326-6066.CIR-13-0008

Published: 10 July 2013

View article titled, Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo

Includes: Supplementary data

NARROW

Abstract A85: Identification and enrichment for rare naturally occurring tumor-reactive T cells in the tumor microenvironment reveals new and diverse opportunities for cancer immunotherapy

Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer

CD4⁺ T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8⁺ T-cell Targeting of HER2/neu–Expressing Cancers

T Cells Bearing a Chimeric Antigen Receptor against Prostate-Specific Membrane Antigen Mediate Vascular Disruption and Result in Tumor Regression

Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo

Email alerts

AACR Journals

Abstract A85: Identification and enrichment for rare naturally occurring tumor-reactive T cells in the tumor microenvironment reveals new and diverse opportunities for cancer immunotherapy

Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer

CD4+ T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8+ T-cell Targeting of HER2/neu–Expressing Cancers

T Cells Bearing a Chimeric Antigen Receptor against Prostate-Specific Membrane Antigen Mediate Vascular Disruption and Result in Tumor Regression

Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

CD4⁺ T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8⁺ T-cell Targeting of HER2/neu–Expressing Cancers